Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide

H H Seltzman, Denise N. Fleming, B F Thomas, A F Gilliam, D S McCallion, Roger Guy Pertwee, D R Compton, Billy R. Martin

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

(Dimethylheptyl)anandamide [(16,16-cimethyldocosa-cis-5,8,11,14-tetraenoyl)ethanolamine] (17a) and its amide analogs were synthesized by Wittig coupling of a ylide derived from a fragment of arachidonic acid. These amides were compared to the endogenous cannabinoid receptor ligand arachidonylethanolamide (anandamide, 2a) and its amide analogs in pharmacological assays for potential enhancement of cannabimimetic activities. The receptor affinity to rat brain membranes of the dimethylheptyl (DMH) analogs increased by an order of magnitude in most comparisons to the corresponding anandamides in displacement assays versus the cannabinoid agonist [H-3]CP 55,940 or antagonist [H-3]SR141716A, for which rank order differences in affinity were observed. An order of magnitude enhancement of potency with comparable or higher efficacy in behavioral assays in the mouse tetrad of tests of cannabinoid activity was observed in 17a versus 2a. In contrast, no enhancement in potency for the pentyl to DMH side chain exchange was seen in the mouse vas deferens assay. The data indicate a structural equivalence between classical plant cannabinoids and 2a as well as different receptor-ligand interactions that characterize multiple receptor sites or binding modes.

Original languageEnglish
Pages (from-to)3626-3634
Number of pages9
JournalJournal of Medicinal Chemistry
Volume40
Issue number22
DOIs
Publication statusPublished - 24 Oct 1997

Keywords

  • CANNABINOID RECEPTOR-BINDING
  • ARACHIDONIC-ACID
  • BRAIN CONSTITUENT
  • CROSS-TOLERANCE
  • HIGH-AFFINITY
  • VAS-DEFERENS
  • RAT-BRAIN
  • IN-VIVO
  • AGONIST
  • MICE

Cite this

Seltzman, H. H., Fleming, D. N., Thomas, B. F., Gilliam, A. F., McCallion, D. S., Pertwee, R. G., ... Martin, B. R. (1997). Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. Journal of Medicinal Chemistry, 40(22), 3626-3634. https://doi.org/10.1021/jm9702950

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. / Seltzman, H H ; Fleming, Denise N. ; Thomas, B F ; Gilliam, A F ; McCallion, D S ; Pertwee, Roger Guy; Compton, D R ; Martin, Billy R. .

In: Journal of Medicinal Chemistry, Vol. 40, No. 22, 24.10.1997, p. 3626-3634.

Research output: Contribution to journalArticle

Seltzman, HH, Fleming, DN, Thomas, BF, Gilliam, AF, McCallion, DS, Pertwee, RG, Compton, DR & Martin, BR 1997, 'Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide' Journal of Medicinal Chemistry, vol. 40, no. 22, pp. 3626-3634. https://doi.org/10.1021/jm9702950
Seltzman, H H ; Fleming, Denise N. ; Thomas, B F ; Gilliam, A F ; McCallion, D S ; Pertwee, Roger Guy ; Compton, D R ; Martin, Billy R. . / Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. In: Journal of Medicinal Chemistry. 1997 ; Vol. 40, No. 22. pp. 3626-3634.
@article{a0ad3bc075284baca13d32419f85ce6f,
title = "Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide",
abstract = "(Dimethylheptyl)anandamide [(16,16-cimethyldocosa-cis-5,8,11,14-tetraenoyl)ethanolamine] (17a) and its amide analogs were synthesized by Wittig coupling of a ylide derived from a fragment of arachidonic acid. These amides were compared to the endogenous cannabinoid receptor ligand arachidonylethanolamide (anandamide, 2a) and its amide analogs in pharmacological assays for potential enhancement of cannabimimetic activities. The receptor affinity to rat brain membranes of the dimethylheptyl (DMH) analogs increased by an order of magnitude in most comparisons to the corresponding anandamides in displacement assays versus the cannabinoid agonist [H-3]CP 55,940 or antagonist [H-3]SR141716A, for which rank order differences in affinity were observed. An order of magnitude enhancement of potency with comparable or higher efficacy in behavioral assays in the mouse tetrad of tests of cannabinoid activity was observed in 17a versus 2a. In contrast, no enhancement in potency for the pentyl to DMH side chain exchange was seen in the mouse vas deferens assay. The data indicate a structural equivalence between classical plant cannabinoids and 2a as well as different receptor-ligand interactions that characterize multiple receptor sites or binding modes.",
keywords = "CANNABINOID RECEPTOR-BINDING, ARACHIDONIC-ACID, BRAIN CONSTITUENT, CROSS-TOLERANCE, HIGH-AFFINITY, VAS-DEFERENS, RAT-BRAIN, IN-VIVO, AGONIST, MICE",
author = "Seltzman, {H H} and Fleming, {Denise N.} and Thomas, {B F} and Gilliam, {A F} and McCallion, {D S} and Pertwee, {Roger Guy} and Compton, {D R} and Martin, {Billy R.}",
year = "1997",
month = "10",
day = "24",
doi = "10.1021/jm9702950",
language = "English",
volume = "40",
pages = "3626--3634",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "AMER CHEMICAL SOC",
number = "22",

}

TY - JOUR

T1 - Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide

AU - Seltzman, H H

AU - Fleming, Denise N.

AU - Thomas, B F

AU - Gilliam, A F

AU - McCallion, D S

AU - Pertwee, Roger Guy

AU - Compton, D R

AU - Martin, Billy R.

PY - 1997/10/24

Y1 - 1997/10/24

N2 - (Dimethylheptyl)anandamide [(16,16-cimethyldocosa-cis-5,8,11,14-tetraenoyl)ethanolamine] (17a) and its amide analogs were synthesized by Wittig coupling of a ylide derived from a fragment of arachidonic acid. These amides were compared to the endogenous cannabinoid receptor ligand arachidonylethanolamide (anandamide, 2a) and its amide analogs in pharmacological assays for potential enhancement of cannabimimetic activities. The receptor affinity to rat brain membranes of the dimethylheptyl (DMH) analogs increased by an order of magnitude in most comparisons to the corresponding anandamides in displacement assays versus the cannabinoid agonist [H-3]CP 55,940 or antagonist [H-3]SR141716A, for which rank order differences in affinity were observed. An order of magnitude enhancement of potency with comparable or higher efficacy in behavioral assays in the mouse tetrad of tests of cannabinoid activity was observed in 17a versus 2a. In contrast, no enhancement in potency for the pentyl to DMH side chain exchange was seen in the mouse vas deferens assay. The data indicate a structural equivalence between classical plant cannabinoids and 2a as well as different receptor-ligand interactions that characterize multiple receptor sites or binding modes.

AB - (Dimethylheptyl)anandamide [(16,16-cimethyldocosa-cis-5,8,11,14-tetraenoyl)ethanolamine] (17a) and its amide analogs were synthesized by Wittig coupling of a ylide derived from a fragment of arachidonic acid. These amides were compared to the endogenous cannabinoid receptor ligand arachidonylethanolamide (anandamide, 2a) and its amide analogs in pharmacological assays for potential enhancement of cannabimimetic activities. The receptor affinity to rat brain membranes of the dimethylheptyl (DMH) analogs increased by an order of magnitude in most comparisons to the corresponding anandamides in displacement assays versus the cannabinoid agonist [H-3]CP 55,940 or antagonist [H-3]SR141716A, for which rank order differences in affinity were observed. An order of magnitude enhancement of potency with comparable or higher efficacy in behavioral assays in the mouse tetrad of tests of cannabinoid activity was observed in 17a versus 2a. In contrast, no enhancement in potency for the pentyl to DMH side chain exchange was seen in the mouse vas deferens assay. The data indicate a structural equivalence between classical plant cannabinoids and 2a as well as different receptor-ligand interactions that characterize multiple receptor sites or binding modes.

KW - CANNABINOID RECEPTOR-BINDING

KW - ARACHIDONIC-ACID

KW - BRAIN CONSTITUENT

KW - CROSS-TOLERANCE

KW - HIGH-AFFINITY

KW - VAS-DEFERENS

KW - RAT-BRAIN

KW - IN-VIVO

KW - AGONIST

KW - MICE

U2 - 10.1021/jm9702950

DO - 10.1021/jm9702950

M3 - Article

VL - 40

SP - 3626

EP - 3634

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 22

ER -